Intracranial meningioma in dogs and cats: A comparative review

Compendium: Continuing Education For Veterinarians

Volumn 31, Issue 7, 2009, Pages 330-339

  Sessums, Kara ^a   Mariani, Christopher ^b  

^a Veterinary Emergency and Referral Group   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; BREEDING; CAT; CAT DISEASE; COMPARATIVE STUDY; DOG; DOG DISEASE; MENINGIOMA; PROGNOSIS; REVIEW; RISK FACTOR; SPECIES DIFFERENCE; TREATMENT OUTCOME;

ANIMALS; BREEDING; CAT DISEASES; CATS; DOG DISEASES; DOGS; MENINGEAL NEOPLASMS; MENINGIOMA; PROGNOSIS; RISK FACTORS; SPECIES SPECIFICITY; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 69549090354     PISSN: 19408307     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Dewey CW. Encephalopathies: disorders of the brain. In: Dewey CW, ed. A Practical Guide to Canine and Feline Neurology. Ames: Iowa State University Press; 2003:127-136.
2. LeCouteur RA. Tumors of the nervous system. In: Withrow SJ, MacEwen EG, eds. Small Animal Clinical Oncology. Philadelphia: WB Saunders; 2001:500-531.
3. Bagley RS, Gavin PR, Moore MP, et al. Clinical signs associated with brain tumors in dogs: 97 cases (1992-1997). JAVMA 1999;215(6):818-819.
4. Troxel MT, Vite CH, Van Winkle TJ, et al. Feline intracranial neoplasia: retrospective review of 160 cases (1985-2001). J Vet Intern Med 2003;17(6):850-859.
5. McDermott MW, Quinones-Hinosa A, Fuller GN, et al. Meningiomas. In: Levin VA, ed. Cancer in the Nervous System. Oxford, UK: University Press; 2002:269-299.
6. Oakley RE, Patterson JS. Tumors of the central and peripheral nervous system. In: Slatter D, ed. Textbook of Small Animal Surgery. Philadelphia: Elsevier Science; 2003:2405-2425.
7. Gordon LE, Thacher C, Matthiesen DT, et al. Results of craniotomy for the treatment of cerebral meningioma in 42 cats. Vet Surg 1994;23(2):94-100.
8. Snyder JM, Shofer FS, Van Winkle TJ, et al. Canine intracranial primary neoplasia: 173 cases (1986-2003). J Vet Intern Med 2006;12(3):669-675.
9. Axlund TW, McGlasson ML, Smith AN. Surgery alone or in combination with radiation therapy for treatment of intracranial meningiomas in dogs: 31 cases (1989-2002). JAVMA 2002;221(11):1597-1600.
10. Tomek A, Cizinauskas S, Doher M, et al. Intracranial neoplasia in 61 cats: localisation, tumour types and seizure patterns. J Feline Med Surg 2006;8:243-253.
11. Morantz RA, Walsh JW. Brain Tumors: A Comprehensive Text. New York: Marcel Dekken 1994.
12. Forterre F, Tomek A, Konar M, et al. Multiple meningiomas: clinical, radiological, surgical and pathological findings with outcome in four cats. J Feline Med Surg 2007;9(1):36-43.
13. Lu D, Pocknell A, Lamb CR, et al. Concurrent benign and malignant multiple meningiomas in a cat: clinical, MRI and pathological findings. Vet Rec 2003;152(25)780-782.
14. Summers BA, Cummings JF, de Lahunta A. Veterinary Neuropathology St. Louis: Mosby-Year Book; 1995.
15. Smith TW, Folkerth RD, Poirier J, et al. Tumors of the nervous system. In: Gray F, De Girolami U, Poirier J, eds. Manual of Basic Neuropathology. Philadelphia: Butterworth-Heinemann; 2004:21-56.
16. Braund KG. Clinical Syndromes in Veterinary Neurology. St. Louis: Mosby; 1994.
17. Patnaik AK, Kay WJ, Hurvitz AL. Intracranial meningioma, a comparative pathologic study of 28 dogs. Vet Pathol 1986;23(4):369-373.
18. Maeda H, Shibuya H, Suzuki K, et al. A case of anaplastic meningioma in a dog. J Vet Med Sci 2005;67(11):1177-1180.
19. Hsu DW, Efird JT, Hedley-White ET. MIB-1 (Ki-67) index and transforming growth factor-alpha (TGHa) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol 1998;24(6):441-452.
20. Sessums K, Mariani CL. Analysis of KI-67, matrix metallinoproteinase 2 and cathepsin B in canine intracranial meningiomas. J Vet Intern Med 2007;21(3):640-641.
21. Forterre F, Fritsch G, Kaiser S, et al. Surgical approach for tentorial meningiomas in cats: a review of six cases. J Feline Med Surg 2006;8:227-233.
22. Kitagawa M, Kanayama K, Sakai T. Cystic meningioma in a dog. J Small Anim Pract 2002;43(6):272-274.
23. Konstantinidou AE, Korkolopoulou P, Mahera H, et al. Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 2003;43(3):280-290.
24. Adamo PF, Cantile C, Steinberg H. Evaluation of progesterone and estrogen receptor expression in 15 meningiomas of dogs and cats. Am J Vet Res 2003;64(10):1310-1318.
25. Mandara MT, Ricci G, Rinaldi L, et al. Immunohistochemical identification and image analysis quantification of oestrogen and progesterone receptors in canine and feline meningioma. J Comp Pathol 2002;127(3):214-218.
26. O'Brien DP, Axlund TW. Brain disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. St. Louis: Elsevier; 2005:830-833.
27. Halpin SF. Supratentorial tumours. In: Gillespie JE, Jackson A, eds. MRI and CT of the Brain. London: Arnold; 2000:122-125.
28. Troxel MT, Vite CH, Massicotte C, et al. Magnetic resonance imaging features of feline intracranial neoplasia: retrospective analysis of 46 cats. J Vet Intem Med 2004;18(2):176-189.
29. Polizopoulou ZS, Koutinas AF, Souftas VD, et al. Diagnostics correlation of CT-MRI and histopathology in 10 dogs with brain neoplasms. J Vet Med Series A 2004;51(5):226-231.
30. Bailey CS, Higgins RJ. Characteristics of cisternal cerebrospinal fluid associated with primary brain tumors in the dog: a retrospective study. JAVMA 1986;188(4):414-417.
31. Dickinson PJ, Sturges BK, Kass PH, LeCouteur RA. Characteristics of cisternal cerebrospinal fluid associated with intracranial meningiomas in dogs: 56 cases (1985-2004). JAVMA 2006;228(4):564-567.
32. Koblik PD, LeCouteur RA, Higgins RJ, et al. CT-guided brain biopsy using a modified Pelorus mark III stereotactic system: experience with 50 dogs. Vet Radiol Ultrasound 1999;40(4):434-440.
33. Adamo PF, Forrest LF, Dubielzig R. Canine and feline meningiomas: diagnosis, treatment and prognosis. Compend Contin Educ Pract Vet 2004;27:951-966.
34. Podell, M. Seizures. In: Platt SR, Olby NJ, eds. BSAVA Manual of Canine and Feline Neurology. Gloucester, UK: Woodrow House; 2004:97-112.
35. Thomas WB. Seizures and narcolepsy. In: Dewey CW, ed. A Practical Guide to Canine and Feline Neurology. Ames: Iowa State University Press; 2003:193-212.
36. Bilderback A, Faissler D, Sato AF, et al. Transfrontal craniectomy, radiation therapy, and/or chemotherapy in the treatment of canine meningiomas [abstract]. Proc 24th ACVIM 2006.
37. Oakley RE, Patterson JS. Tumors of the central and peripheral nervous system. In: Slatter D, ed. Textbook of Small Animal Surgery. Philadelphia: Elsevier Science; 2003:2405-2425.
38. Gallagher JG, Berg J, Knowles KE, et al. Prognosis after surgical excision of cerebral meningioma in cats: 17 cases (1986-1992). JAVMA 1993:203(10):1437-1440.
39. Bagley RS. Fundamentals of Veterinary Clinical Neurology. Ames, Iowa: Blackwell Publishing; 2005.
40. Niebauer GW, Dayrell-Hart BL, Speciale J. Evaluation of craniotomy in dogs and cats. JAVMA 1991;198(1):89-95.
41. Theon AP, LeCouteur RA, Carr EA, Griffey SM. Influence of tumor cell proliferation and sex-hormone receptors on effectiveness of radiation therapy for dogs with incompletely resected meningiomas. JAVMA 2000;216(5):701-707.
42. Greco JJ, Aiken SA, Berg JM, et al. Evaluation of intracranial meningioma resection with a surgical aspirator in dogs: 17 cases (1996-2004). JAVMA 2006;229(3):394-400.
43. Berg JM. Canine meningiomas, other approaches: hydroxyurea and ultrasonic aspiration. Proc 23rd ACVIM 2004.
44. Bagley RS. Coma, stupor and behavioural change. In: Platt SR, Olby NJ, eds. BSAVA Manual of Canine and Feline Neurology. Gloucester, UK: BSAVA; 2004:126-128.
45. Brearley MJ, Jeffery ND, Phillips SM, Dennis R. Hypofractionated radiation therapy of brain masses in dogs: a retrospective analysis of survival of 83 cases (1991-1996). J Vet Intern Med 1999;13:408-412.
46. Heidner GL, Kornegay JN, Page RL, et al. Analysis of survival in a retrospective study of 86 dogs with brain tumors. J Vet Intern Med 1991;(5)4:219-226.
47. Spugnini EP, Thrall OE, Price GS, et al. Primary irradiation of canine intracranial masses. Vet Radiol Ultrasound 2000;41(4):377-380.
48. Bley CR, Sumova A, Roos M, et al. Irradiation of brain tumors in dogs with neurologic disease. J Vet Intern Med 2005;19:849-854.
49. Friedman WA, Foote KD. Linear accelerator-based radiosurgery for vestibular schwannoma. Neurosurg Focus 2003;14(5):1-8.
50. Lester NV, Hopkins AL, Bova FJ, et al. Radiosurgery using a stereotactic headframe system for irradiation of brain tumors in dogs. JAVMA 2001;219(11):1562-1567.
51. Kollova A, Lisca KR, Novotna J, et al. Gamma knife surgery for benign meningioma. J Neurosurg 2007;107(2):325-336.
52. Henzel M, Gross MW, Hamm K, et al. Significant tumor volume reduction of meningiomas after stereotactic radiotherapy: results of a prospective multicenter study. Neurosurgery 2006;59(6):1188-1194.
53. Jung Dl, Kim HJ, Park C, et al. Long-term chemotherapy with lomustine of intracranial meningioma occurring in a miniature Schnauzer. J Vet Med Sci 2006;68(4):383-386.
54. Schrell UM, Rittig MG, Anders M, et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 1997;86(5):845-852.
55. Schrell UM, Rittig MG, Anders M, et al. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 1997;86(5):840-844.
56. Hahn BM, Schrell UM, Sauer R, et al. Prolonged oral hydroxyurea and concurrent 3D-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study. J Neurooncol 2005;74(2):157-165.
57. Dewey CW. Hydroxyurea and meningiomas. Veterinary Information Network. Accessed February 2009 at www.vin.com.
58. Alekhteyar KM, Glatstein E. Radiotherapy management of brain tumors. In: Kornblith PL, Walker MD, eds. Advances in Neuro-Oncology II. New York: Futura; 1997:316-317.
59. Chauvet AE, Kesava PP, Goh CS, et al. Selective intraarterial gene delivery into a canine meningioma. J Neurosurg 1998;88:870-873.
60. Kumar PP, Patil AA, Syh HW, et al. Role of brachytherapy in the management of the skull base meningioma. Cancer 1993;71:3726-3731.
61. Ingram M, Jacques D, Freshwater D, et al. Adoptive immunotherapy of brain tumors in dogs. Vet Med Rep 1990;2:398-402.